EndoSphere Company
Endosphere is a developer of the novel endo-metabolic device category that provides non-invasive endoscopic therapies for gastrointestinal (GI) disorders and metabolic diseases including obesity, non-alcoholic fatty liver disease, type 2 diabetes, and drug delivery. It treats obesity using the body's natural physiology that enables patients to safely and effectively lose weight without the need for surgery or medications. Endosphere was founded in 2006 and is headquartered in Columbus, Ohio.
Industry:
P4 Medicine
Headquarters:
Columbus, Ohio, United States
Zip:
1-10
Founded Date:
2006-01-01
Employees Number:
1-10
Acquisitions Number:
7
Investors Number:
14100000
Total Funding:
$10M to $50M
Estimated Revenue:
$10M to $50M
Last Funding Date:
Series C
Last Funding Type:
Series C
Register and Claim Ownership